Katherine Lazar

Katherine (Kate) Lazar is a Principal, Portfolio Strategy. Ms. Lazar joined the Firm in 2016 as a Fellow before serving as an associate on the Firm's Therapeutics team. She holds a B.A. in Linguistics from Minsk State Linguistics University, a B.S. in Biology with a minor in Chemistry from The City University of New York and an M.S. in Biotechnology from Johns Hopkins University.